PSY38 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 400mg Daily in Newly Diagnosed Patients With Chronic Myeloid Leukemia (CML)

✍ Scribed by S. Mealing; M. Taylor; D. Scott; J. Clark; M. Mckenna; M. Lebmeier; I. Gilloteau; C. Davis

• Book ID: 119311505
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 61 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.03.572